Nichi-Iko still has a long road to recovery ahead as it attempts to get its Toyama plant back on its feet.
Earnings recovery for Nichi-Iko Pharmaceutical Co., Ltd. appears unlikely until the full resumption of shipments from its Toyama plant. Despite securing a 9.6% year-on-year revenue rise to ¥47bn ($330m) during its financial Q1 ended 30 June 2022 due to increased sales volume, operating losses expanded to ¥6.5bn compared to ¥4.1bn during the prior year.
Nichi-Iko explained that “due to stringent quality checks and other measures, it is talking longer than originally expected to resume...
Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.
We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
